References - Therapeutic Strategies in Cancer Biology and Pathology - page 208

El-Tanani, M., Platt-Higgins, A., Rudland, P.S., Campbell, F.C., 2004. Ets gene PEA3 cooper-
ates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J. Biol.
Chem. 279, 20794-20806.
Emoto, S., Ishigami, H., Yamashita, H., Yamaguchi, H., Kaisaki, S., Kitayama, J., 2012.
Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemina-
tion. Gastric Cancer 15, 154-161.
Endsley, M.P., Hu, Y., Deng, Y., He, X., Warejcka, D.J., Twining, S.S., et al., 2011. Maspin,
the molecular bridge between the plasminogen activator system and beta 1 integrin that
facilitates cell adhesion. J. Biol. Chem. 286, 24599-24607.
Engelman, J.A., Zejnullahu, K., Misutomi, T., Song, Y., Hyland, C., Park, J.O., et al., 2007.
MET amplification leads to gefitinib resistance in lung Cancer by activating ERBB3
aignaling. Science 316, 1039-1043.
Engels, K., Giannattasio, M., Muzi-Falconi, M., Lopes, M., Ferrari, S., 2011. 14-3-3 proteins
regulate exonuclease 1-dependent processing of stalled replication forks. PloS Genet. 7,
e1001367.
Ergen, A., Canbay, E., Bugra, D., Zeybek, U., Yamaner, S., Bulut, T., 2012. Plasma
Kisspeptin-54 levels in gastric cancer patients. Int. J. Surg. 10, 551-554.
Ernst, C., Christie, B.R., 2006. The putative neural stem cell marker, nestin, is expressed in
heterogeneous cell types in the adult rat neocortex. Neuroscience 138, 183-188.
Esteller, M., 2011. Non-coding RNAs in human disease. Nat. Rev. Gen. 12, 861-874.
Esteller, M., Avizienyte, E., Corn, P.G., Lothe, R.A., Baylin, S.B., Aaltonen, L.A., et al., 2000.
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers
syndrome. Oncogene 19, 164-168.
Eves, E.M., Shapiro, P., Naik, K., Klein, U.R., Trakul, N., Rosner, M.R., 2006. Raf kinase inhib-
itory protein regulates Aurora B kinase and the spindle checkpoint. Mol. Cell. 23, 561-574.
Evren, S., Dermen, A., Lockwood, G., Fleshner, N., Sweet, J., 2011. mTOR-RAPTOR and 14-3-3
sigma immunohistochemical expression in high grade prostatic intraepithelial neoplasia and
prostatic adenocarcinomas: a tissue microarray study. J. Clin. Pathol. 64, 683-688.
Evron, T., Philipp, M., Lu, J., Meloni, A.R., Burkhalter, M., Chen, W., et al., 2011. Growth
Arrest Specific 8 (Gas8) and G protein-coupled receptor kinase 2 (GRK2) cooperate in
the control of Smoothened signaling. J. Biol. Chem. 286, 27676-27686.
Fan, C., Yu, J., Liu, Y., Xu, H., Wang, E., 2012. Increased NDRG1 expression is associated
with advanced T stages and poor vascularization in non-small cell lung cancer. Pathol.
Oncol. Res. 18, 549-556.
Fang, J.H., Zhou, H.C., Zeng, C., Yang, J., Liu, Y., Huang, X., et al., 2011. MicroRNA-29b
suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metallopro-
teinase 2 expression. Heptology 54, 1729-1740.
Fassina, A., Cappellesso, R., Guzzardo, V., Dalla Via, L., Piccolo, S., Ventura, L., et al., 2012.
Epithelial-mesenchymal transition in malignant mesothelioma. Mod. Pathol. 25, 86-99.
Fendrich, V., Wiese, D., Waldmann, J., Lauth, M., Heverhagen, A.E., Rehm, J., et al., 2011.
Hedgehog inhibition with the orally bioavailable Smo antagonist LDE225 represses
tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms.
Ann. Surg. 254, 818-823.
Feng, C., Neumeister, V., Ma, W., Xu, J., Lu, L., Bordeaux, J., et al., 2012. Lin28 regu-
lates HER2 and promotes malignancy through multiple mechanisms. Cell Cycle 11,
2486-2494.
Feng, D.D., Zhang, H., Zhang, P., Zheng, Y.S., Zhang, X.J., Han, B.W., et al., 2011a. Down-
regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and
relapse in leukaemia. J. Cell. Mol. Med. 15, 2164-2175.